Trial Profile
Safety and pharmacodynamic study of treprostinil in patients with systemic sclerosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Dec 2015
Price :
$35
*
At a glance
- Drugs Treprostinil (Primary)
- Indications Systemic scleroderma
- Focus Adverse reactions; Pharmacodynamics
- 28 Dec 2015 New trial record